A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease

Hierarchical Data-Driven Analysis of Clinical Symptoms Among Patients With Parkinson's Disease

(2019) Tal Kozlovski et al.   Frontiers in Neurology

Parkinson’s Disease in Women and Men: What’s the Difference?

(2019) Silvia Cerri et al.   Journal of Parkinsons Disease

Glucocerebrosidase and its relevance to Parkinson disease

(2019) Jenny Do et al.   Molecular Neurodegeneration

Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?

(2019) Orly Goldstein et al.   MOLECULAR GENETICS AND METABOLISM

Sex differences in Parkinson's disease presentation and progression

(2019) Danielle S. Abraham et al.   PARKINSONISM & RELATED DISORDERS

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients

(2019) Daniel Ysselstein et al.   Nature Communications

Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene

(2018) Avner Thaler et al.   PARKINSONISM & RELATED DISORDERS

Progression in the LRRK2-Associated Parkinson Disease Population

(2018) Rachel Saunders-Pullman et al.   JAMA Neurology

Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels

(2018) Anna Lisa Gündner et al.   NEUROBIOLOGY OF DISEASE

LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase

(2018) Dong Hwan Ho et al.   CELL BIOCHEMISTRY AND FUNCTION

Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations

(2018) Gilad Yahalom et al.   PARKINSONISM & RELATED DISORDERS

Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature

(2017) Susanne A. Schneider et al.   MOVEMENT DISORDERS

A “dose” effect of mutations in the GBA gene on Parkinson's disease phenotype

(2017) Avner Thaler et al.   PARKINSONISM & RELATED DISORDERS

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's

(2016) Ganqiang Liu et al.   ANNALS OF NEUROLOGY

Survival and dementia inGBA-associated Parkinson's disease: The mutation matters

(2016) Roberto Cilia et al.   ANNALS OF NEUROLOGY

Neuropsychiatric characteristics of GBA-associated Parkinson disease

(2016) Matthew Swan et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease

(2014) Karen E. Murphy et al.   BRAIN

Parkinson disease phenotype in Ashkenazi jews with and withoutLRRK2G2019S mutations

(2013) Roy N. Alcalay et al.   MOVEMENT DISORDERS

Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation

(2013) Anat Mirelman et al.   MOVEMENT DISORDERS

Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains

(2012) Matthew E. Gegg et al.   ANNALS OF NEUROLOGY

Estimation of Parkinson’s disease survival in Israeli men and women, using health maintenance organization pharmacy data in a unique approach

(2012) O. Chillag-Talmor et al.   JOURNAL OF NEUROLOGY

Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies

(2011) Joseph R. Mazzulli et al.   CELL

LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease

(2009) Z. Gan-Or et al.   NEUROGENETICS

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

(2008) Anthony HV Schapira   LANCET NEUROLOGY

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset

(2008) Z. Gan-Or et al.   NEUROLOGY